Oxford Asset Management’s Viridian Therapeutics VRDN Stock Holding History

Oxford Asset Management’s Portfolio VRDN Stock Details VRDN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell
2018 Q4	$252K	Buy
2018 Q3	$218K	Buy
2018 Q1	–	Sell
2017 Q4	$321K	Buy